1. Home
  2. CDP vs ZLAB Comparison

CDP vs ZLAB Comparison

Compare CDP & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDP
  • ZLAB
  • Stock Information
  • Founded
  • CDP 1988
  • ZLAB 2013
  • Country
  • CDP United States
  • ZLAB China
  • Employees
  • CDP N/A
  • ZLAB N/A
  • Industry
  • CDP Real Estate Investment Trusts
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CDP Real Estate
  • ZLAB Health Care
  • Exchange
  • CDP Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • CDP 3.5B
  • ZLAB 3.0B
  • IPO Year
  • CDP N/A
  • ZLAB 2017
  • Fundamental
  • Price
  • CDP $29.58
  • ZLAB $26.05
  • Analyst Decision
  • CDP Buy
  • ZLAB Strong Buy
  • Analyst Count
  • CDP 7
  • ZLAB 3
  • Target Price
  • CDP $33.14
  • ZLAB $55.00
  • AVG Volume (30 Days)
  • CDP 730.1K
  • ZLAB 482.4K
  • Earning Date
  • CDP 02-06-2025
  • ZLAB 02-25-2025
  • Dividend Yield
  • CDP 3.99%
  • ZLAB N/A
  • EPS Growth
  • CDP N/A
  • ZLAB N/A
  • EPS
  • CDP 1.21
  • ZLAB N/A
  • Revenue
  • CDP $749,503,000.00
  • ZLAB $355,748,000.00
  • Revenue This Year
  • CDP N/A
  • ZLAB $49.04
  • Revenue Next Year
  • CDP $4.59
  • ZLAB $46.70
  • P/E Ratio
  • CDP $24.50
  • ZLAB N/A
  • Revenue Growth
  • CDP 10.11
  • ZLAB 35.01
  • 52 Week Low
  • CDP $22.20
  • ZLAB $13.48
  • 52 Week High
  • CDP $34.22
  • ZLAB $36.60
  • Technical
  • Relative Strength Index (RSI)
  • CDP 34.72
  • ZLAB 50.14
  • Support Level
  • CDP $28.88
  • ZLAB $23.82
  • Resistance Level
  • CDP $30.44
  • ZLAB $25.64
  • Average True Range (ATR)
  • CDP 0.53
  • ZLAB 1.24
  • MACD
  • CDP -0.07
  • ZLAB 0.06
  • Stochastic Oscillator
  • CDP 26.82
  • ZLAB 64.45

About CDP COPT Defense Properties of Beneficial Interest

COPT Defense Properties is a real estate investment trust that acquires, manages, and leases office and data center properties throughout the U.S. The majority of the company's real estate portfolio is composed of office buildings in the Baltimore-Washington Corridor and Northern Virginia area. COPT derives nearly all of its income in the form of rental revenue from tenants. Most of the company's revenue comes from the leasing of properties to U.S. Government agencies and its contractors in the national security, defense, and IT sectors, such as Northrop Grumman and Boeing. Regional offices in urban submarkets make also make up a sizable percentage of COPT's total square footage.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Share on Social Networks: